
1. oncogene. 2010 apr 15;29(15):2205-16. doi: 10.1038/onc.2009.507. epub 2010 jan
25.

rac1 required oncolytic ndv replication human cancer cells and
establishes link tumorigenesis sensitivity oncolytic virus.

puhlmann j(1), puehler f, mumberg d, boukamp p, beier r.

author information: 
(1)bayer schering pharma ag, global drug discovery, berlin, germany.

oncolytic newcastle disease virus (ndv) replicates selectively human
tumor cells normal cells. relationship tumorigenesis and
the selective susceptibility tumor cells oncolytic ndv replication 
poorly understood. multistage skin carcinogenesis model derived from
non-tumorigenic hacat cells used systematically investigate molecular 
mechanisms involved oncolytic ndv-sensitivity associated tumorigenic 
transformation. significant differences interferon signaling observed 
between virus-sensitive tumor cells virus-resistant non-tumorigenic
parental cells. oncogenic h-ras, used tumorigenic
transformation, shown necessary virus replication not
sufficient render cells susceptible ndv replication. using sirna
screening approach search virus-sensitizing genes tumorigenic
cells, could identify small gtpase rac1 oncogenic protein is
essential ndv replication anchorage-independent growth tumorigenic
cells. furthermore, rac1 expression sufficient render non-tumorigenic
cells susceptible ndv replication oncolytic cytotoxicity. study
establishes rac1 link tumorigenesis oncolytic virus sensitivity 
in hacat multistage skin carcinogenesis model.

doi: 10.1038/onc.2009.507 
pmid: 20101224  [indexed medline]

